ÂÜÀòÂÒÂ×

Kevin Chu is a Principal on the healthcare team at F-Prime Capital. Prior to F-Prime Capital, Kevin was an Associate Consultant with IMS Consulting Group in New York, where he advised biopharmaceutical clients on development and commercial strategy across multiple therapeutic areas.

Kevin is currently based in the San Francisco office, and works across the healthcare sub-sectors including Therapeutics, MedTech, and Healthcare IT and Services, and also works closely with Eight Roads Ventures China healthcare team to manage F-Prime’s existing and new investment efforts in China.